The news: Dr. Cheryl Pegus, who joined Walmart in December 2020 as executive vice president of its health and wellness division, is leaving for a position as managing director at JP Morgan’s healthcare arm, per Bloomberg.
How we got here: Walmart Health has gone from being a potential frontrunner in delivering healthcare to almost an after-thought against rivals CVS Health and Walgreens.
Why it matters: Pegus’ departure could signal another round of exits at Walmart Health.
Our take: The retail health phenomenon shows no signs of slowing down going into 2023.
Walmart’s retail rivals include Amazon, CVS Health, and Walgreens—all of which are actively buying and building primary care networks and pushing toward in-home care services.
Walmart Health could have been a major healthcare disruptor—and still could be. The idea of providing high-quality, lower-cost healthcare services to people in medically underserved communities isn’t new. Walmart Health’s clinics are an interesting approach, but not on the current scale. However, if Walmart Health leveraged the US retail chain’s scale and physically provided those services across 4,000 US stores—that would be a game changer.
Go deeper: Check out our recently published report, The Power of Walmart
This article originally appeared in Insider Intelligence's Digital Health Briefing—a daily recap of top stories reshaping the healthcare industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.
11 Times SquareNew York, NY 100361-800-405-0844